cloudfront

Report Detail



OtherGlobal HIV Diagnostics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

  • RnM2414261
  • |
  • 14 September, 2018
  • |
  • Global
  • |
  • 137 pages
  • |
  • GIR (Global Info Research)
  • |
  • Other

Global HIV Diagnostics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Table of Contents

    1 HIV Diagnostics Market Overview

    • 1.1 Product Overview and Scope of HIV Diagnostics
    • 1.2 Classification of HIV Diagnostics by Types
    • 1.2.1 Global HIV Diagnostics Revenue Comparison by Types (2017-2023)
  • 1.2.2 Global HIV Diagnostics Revenue Market Share by Types in 2017
  • 1.2.3 Consumables
  • 1.2.4 Assay, Kits and Reagents
  • 1.2.5 Other Consumables
  • 1.2.6 Instruments
  • 1.2.7 Software and Services
  • 1.3 Global HIV Diagnostics Market by Application
  • 1.3.1 Global HIV Diagnostics Market Size and Market Share Comparison by Applications (2013-2023)
  • 1.3.2 Antibody Tests
  • 1.3.3 Viral Load Tests
  • 1.3.4 CD4 Tests
  • 1.3.5 Tests for Early Infant Diagnosis
  • 1.3.6 Tests for Viral Identification
  • 1.4 Global HIV Diagnostics Market by Regions
  • 1.4.1 Global HIV Diagnostics Market Size (Million USD) Comparison by Regions (2013-2023)
  • 1.4.1 North America (USA, Canada and Mexico) HIV Diagnostics Status and Prospect (2013-2023)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) HIV Diagnostics Status and Prospect (2013-2023)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) HIV Diagnostics Status and Prospect (2013-2023)
  • 1.4.4 South America (Brazil, Argentina, Colombia) HIV Diagnostics Status and Prospect (2013-2023)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) HIV Diagnostics Status and Prospect (2013-2023)
  • 1.5 Global Market Size of HIV Diagnostics (2013-2023)
  • 2 Manufacturers Profiles

    • 2.1 Alere Inc.
    • 2.1.1 Business Overview
  • 2.1.2 HIV Diagnostics Type and Applications
  • 2.1.2.1 Product A
  • 2.1.2.2 Product B
  • 2.1.3 Alere Inc. HIV Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
  • 2.2 Abbott Healthcare
  • 2.2.1 Business Overview
  • 2.2.2 HIV Diagnostics Type and Applications
  • 2.2.2.1 Product A
  • 2.2.2.2 Product B
  • 2.2.3 Abbott Healthcare HIV Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
  • 2.3 Abbvie Inc.
  • 2.3.1 Business Overview
  • 2.3.2 HIV Diagnostics Type and Applications
  • 2.3.2.1 Product A
  • 2.3.2.2 Product B
  • 2.3.3 Abbvie Inc. HIV Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
  • 2.4 Brsitol-Myers Squibb
  • 2.4.1 Business Overview
  • 2.4.2 HIV Diagnostics Type and Applications
  • 2.4.2.1 Product A
  • 2.4.2.2 Product B
  • 2.4.3 Brsitol-Myers Squibb HIV Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
  • 2.5 Janssen Therapeutics
  • 2.5.1 Business Overview
  • 2.5.2 HIV Diagnostics Type and Applications
  • 2.5.2.1 Product A
  • 2.5.2.2 Product B
  • 2.5.3 Janssen Therapeutics HIV Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
  • 2.6 Gilead Sciences
  • 2.6.1 Business Overview
  • 2.6.2 HIV Diagnostics Type and Applications
  • 2.6.2.1 Product A
  • 2.6.2.2 Product B
  • 2.6.3 Gilead Sciences HIV Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
  • 2.7 Merck & Co. Inc
  • 2.7.1 Business Overview
  • 2.7.2 HIV Diagnostics Type and Applications
  • 2.7.2.1 Product A
  • 2.7.2.2 Product B
  • 2.7.3 Merck & Co. Inc HIV Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
  • 2.8 VIIV Healthcare
  • 2.8.1 Business Overview
  • 2.8.2 HIV Diagnostics Type and Applications
  • 2.8.2.1 Product A
  • 2.8.2.2 Product B
  • 2.8.3 VIIV Healthcare HIV Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
  • 2.9 BD Biosciences
  • 2.9.1 Business Overview
  • 2.9.2 HIV Diagnostics Type and Applications
  • 2.9.2.1 Product A
  • 2.9.2.2 Product B
  • 2.9.3 BD Biosciences HIV Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
  • 2.10 Beckman Coulter
  • 2.10.1 Business Overview
  • 2.10.2 HIV Diagnostics Type and Applications
  • 2.10.2.1 Product A
  • 2.10.2.2 Product B
  • 2.10.3 Beckman Coulter HIV Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
  • 2.11 Partec
  • 2.11.1 Business Overview
  • 2.11.2 HIV Diagnostics Type and Applications
  • 2.11.2.1 Product A
  • 2.11.2.2 Product B
  • 2.11.3 Partec HIV Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
  • 2.12 Sysmex
  • 2.12.1 Business Overview
  • 2.12.2 HIV Diagnostics Type and Applications
  • 2.12.2.1 Product A
  • 2.12.2.2 Product B
  • 2.12.3 Sysmex HIV Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
  • 2.13 Apogee Flow Systems
  • 2.13.1 Business Overview
  • 2.13.2 HIV Diagnostics Type and Applications
  • 2.13.2.1 Product A
  • 2.13.2.2 Product B
  • 2.13.3 Apogee Flow Systems HIV Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
  • 2.14 PointCare Technologies Inc.
  • 2.14.1 Business Overview
  • 2.14.2 HIV Diagnostics Type and Applications
  • 2.14.2.1 Product A
  • 2.14.2.2 Product B
  • 2.14.3 PointCare Technologies Inc. HIV Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
  • 2.15 Zyomyx Inc.
  • 2.15.1 Business Overview
  • 2.15.2 HIV Diagnostics Type and Applications
  • 2.15.2.1 Product A
  • 2.15.2.2 Product B
  • 2.15.3 Zyomyx Inc. HIV Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
  • 2.16 Mylan inc.
  • 2.16.1 Business Overview
  • 2.16.2 HIV Diagnostics Type and Applications
  • 2.16.2.1 Product A
  • 2.16.2.2 Product B
  • 2.16.3 Mylan inc. HIV Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
  • 2.17 Roche Diagnostics
  • 2.17.1 Business Overview
  • 2.17.2 HIV Diagnostics Type and Applications
  • 2.17.2.1 Product A
  • 2.17.2.2 Product B
  • 2.17.3 Roche Diagnostics HIV Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
  • 2.18 Siemens Healthcare
  • 2.18.1 Business Overview
  • 2.18.2 HIV Diagnostics Type and Applications
  • 2.18.2.1 Product A
  • 2.18.2.2 Product B
  • 2.18.3 Siemens Healthcare HIV Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
  • 2.19 Qiagen
  • 2.19.1 Business Overview
  • 2.19.2 HIV Diagnostics Type and Applications
  • 2.19.2.1 Product A
  • 2.19.2.2 Product B
  • 2.19.3 Qiagen HIV Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
  • 2.20 BioMerieux
  • 2.20.1 Business Overview
  • 2.20.2 HIV Diagnostics Type and Applications
  • 2.20.2.1 Product A
  • 2.20.2.2 Product B
  • 2.20.3 BioMerieux HIV Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
  • 3 Global HIV Diagnostics Market Competition, by Players

    • 3.1 Global HIV Diagnostics Revenue and Share by Players (2013-2018)
    • 3.2 Market Concentration Rate
    • 3.2.1 Top 5 HIV Diagnostics Players Market Share
  • 3.2.2 Top 10 HIV Diagnostics Players Market Share
  • 3.3 Market Competition Trend
  • 4 Global HIV Diagnostics Market Size by Regions

    • 4.1 Global HIV Diagnostics Revenue and Market Share by Regions
    • 4.2 North America HIV Diagnostics Revenue and Growth Rate (2013-2018)
    • 4.3 Europe HIV Diagnostics Revenue and Growth Rate (2013-2018)
    • 4.4 Asia-Pacific HIV Diagnostics Revenue and Growth Rate (2013-2018)
    • 4.5 South America HIV Diagnostics Revenue and Growth Rate (2013-2018)
    • 4.6 Middle East and Africa HIV Diagnostics Revenue and Growth Rate (2013-2018)

    5 North America HIV Diagnostics Revenue by Countries

    • 5.1 North America HIV Diagnostics Revenue by Countries (2013-2018)
    • 5.2 USA HIV Diagnostics Revenue and Growth Rate (2013-2018)
    • 5.3 Canada HIV Diagnostics Revenue and Growth Rate (2013-2018)
    • 5.4 Mexico HIV Diagnostics Revenue and Growth Rate (2013-2018)

    6 Europe HIV Diagnostics Revenue by Countries

    • 6.1 Europe HIV Diagnostics Revenue by Countries (2013-2018)
    • 6.2 Germany HIV Diagnostics Revenue and Growth Rate (2013-2018)
    • 6.3 UK HIV Diagnostics Revenue and Growth Rate (2013-2018)
    • 6.4 France HIV Diagnostics Revenue and Growth Rate (2013-2018)
    • 6.5 Russia HIV Diagnostics Revenue and Growth Rate (2013-2018)
    • 6.6 Italy HIV Diagnostics Revenue and Growth Rate (2013-2018)

    7 Asia-Pacific HIV Diagnostics Revenue by Countries

    • 7.1 Asia-Pacific HIV Diagnostics Revenue by Countries (2013-2018)
    • 7.2 China HIV Diagnostics Revenue and Growth Rate (2013-2018)
    • 7.3 Japan HIV Diagnostics Revenue and Growth Rate (2013-2018)
    • 7.4 Korea HIV Diagnostics Revenue and Growth Rate (2013-2018)
    • 7.5 India HIV Diagnostics Revenue and Growth Rate (2013-2018)
    • 7.6 Southeast Asia HIV Diagnostics Revenue and Growth Rate (2013-2018)

    8 South America HIV Diagnostics Revenue by Countries

    • 8.1 South America HIV Diagnostics Revenue by Countries (2013-2018)
    • 8.2 Brazil HIV Diagnostics Revenue and Growth Rate (2013-2018)
    • 8.3 Argentina HIV Diagnostics Revenue and Growth Rate (2013-2018)
    • 8.4 Colombia HIV Diagnostics Revenue and Growth Rate (2013-2018)

    9 Middle East and Africa Revenue HIV Diagnostics by Countries

    • 9.1 Middle East and Africa HIV Diagnostics Revenue by Countries (2013-2018)
    • 9.2 Saudi Arabia HIV Diagnostics Revenue and Growth Rate (2013-2018)
    • 9.3 UAE HIV Diagnostics Revenue and Growth Rate (2013-2018)
    • 9.4 Egypt HIV Diagnostics Revenue and Growth Rate (2013-2018)
    • 9.5 Nigeria HIV Diagnostics Revenue and Growth Rate (2013-2018)
    • 9.6 South Africa HIV Diagnostics Revenue and Growth Rate (2013-2018)

    10 Global HIV Diagnostics Market Segment by Type

    • 10.1 Global HIV Diagnostics Revenue and Market Share by Type (2013-2018)
    • 10.2 Global HIV Diagnostics Market Forecast by Type (2018-2023)
    • 10.3 Consumables Revenue Growth Rate (2013-2023)
    • 10.4 Assay, Kits and Reagents Revenue Growth Rate (2013-2023)
    • 10.5 Other Consumables Revenue Growth Rate (2013-2023)
    • 10.6 Instruments Revenue Growth Rate (2013-2023)
    • 10.7 Software and Services Revenue Growth Rate (2013-2023)

    11 Global HIV Diagnostics Market Segment by Application

    • 11.1 Global HIV Diagnostics Revenue Market Share by Application (2013-2018)
    • 11.2 HIV Diagnostics Market Forecast by Application (2018-2023)
    • 11.3 Antibody Tests Revenue Growth (2013-2018)
    • 11.4 Viral Load Tests Revenue Growth (2013-2018)
    • 11.5 CD4 Tests Revenue Growth (2013-2018)
    • 11.6 Tests for Early Infant Diagnosis Revenue Growth (2013-2018)
    • 11.7 Tests for Viral Identification Revenue Growth (2013-2018)

    12 Global HIV Diagnostics Market Size Forecast (2018-2023)

    • 12.1 Global HIV Diagnostics Market Size Forecast (2018-2023)
    • 12.2 Global HIV Diagnostics Market Forecast by Regions (2018-2023)
    • 12.3 North America HIV Diagnostics Revenue Market Forecast (2018-2023)
    • 12.4 Europe HIV Diagnostics Revenue Market Forecast (2018-2023)
    • 12.5 Asia-Pacific HIV Diagnostics Revenue Market Forecast (2018-2023)
    • 12.6 South America HIV Diagnostics Revenue Market Forecast (2018-2023)
    • 12.7 Middle East and Africa HIV Diagnostics Revenue Market Forecast (2018-2023)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      The HIV diagnostics market encompasses diagnostic screening and confirmatory tests for HIV-1, 2 and group O incidence testing. These tests have primary applications to screen and differentiate between the various groups and subtypes of human immunodeficiency virus.

      Scope of the Report:

      This report studies the HIV Diagnostics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the HIV Diagnostics market by product type and applications/end industries.

      Owing to the technological development of disease diagnostic tests and the anticipated development and commercialization of novel, regulatory authorities approved POC and rapid CD4, p24 antigen and EID tests, it is expected that all the major regional market segments will witness an increase in market demand over the forecast period.

      The global HIV Diagnostics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

      The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

      North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of HIV Diagnostics.

      Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

      Market Segment by Companies, this report covers

      Alere Inc.

      Abbott Healthcare

      Abbvie Inc.

      Brsitol-Myers Squibb

      Janssen Therapeutics

      Gilead Sciences

      Merck & Co. Inc

      VIIV Healthcare

      BD Biosciences

      Beckman Coulter

      Partec

      Sysmex

      Apogee Flow Systems

      PointCare Technologies Inc.

      Zyomyx Inc.

      Mylan inc.

      Roche Diagnostics

      Siemens Healthcare

      Qiagen

      BioMerieux

      Market Segment by Regions, regional analysis covers

      North America (United States, Canada and Mexico)

      Europe (Germany, France, UK, Russia and Italy)

      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

      South America (Brazil, Argentina, Colombia)

      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers

      Consumables

      Assay, Kits and Reagents

      Other Consumables

      Instruments

      Software and Services

      Market Segment by Applications, can be divided into

      Antibody Tests

      Viral Load Tests

      CD4 Tests

      Tests for Early Infant Diagnosis

      Tests for Viral Identification




      Summary:
      Get latest Market Research Reports on HIV Diagnostics . Industry analysis & Market Report on HIV Diagnostics is a syndicated market report, published as Global HIV Diagnostics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023. It is complete Research Study and Industry Analysis of HIV Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,336.82
      3,505.23
      4,673.64
      3,202.30
      4,803.44
      6,404.59
      421,567.20
      632,350.80
      843,134.40
      230,770.63
      346,155.95
      461,541.26
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report